Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM

    NEXT STORY
    American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa
    PREV STORY
    Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations(1)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Centrexion Therapeutics Announces Publication of Phase 2 Efficacy Data on CNTX-4975 for Treatment of Moderate to Severe Knee Osteoarthritis Pain in Arthritis & Rheumatology

    author_avatar
    NASDAQ Market News

    Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine

    author_avatar
    NASDAQ Market News

    DBV Technologies Announces Positive DSMB Review of Part A of Phase III Study in Peanut-Allergic Toddlers

    Montrouge, France, September 12, 2018 DBV Technologies Announces Positive DSMB Review of Part A ...

    author_avatar
    NASDAQ Market News